Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 102

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 102
---
 |
| ● | reviewing                                                                                                                                 
 and approving, or making recommendations to our board of directors regarding, incentive compensation and equity compensation plans;       
 and                                                                                                                                       |
| ● | establishing                                                                                                                              
 and reviewing general policies relating to compensation and benefits of our employees.                                                    |

Our compensation committee will operate under a written charter that satisfies the applicable rules and regulations of the SEC and the listing standards of Nasdaq, a copy of which will be available on our website.

| 58 |

Nominating and Corporate Governance Committee

The nominating and corporate governance committee was established upon the effectiveness of our initial public offering on February 9, 2024 and consists of Dr. Matthew P. Del Giudice and Edward MacPherson, with Matthew P. Del Giudice serving as the chair of the nominating and corporate governance committee. Each member of the committee meets the requirements for independence under the listing standards of Nasdaq and SEC rules and regulations.

Our nominating and corporate governance committee will be responsible for, among other things:

| ● | identifying,                                                                                                                             
 evaluating, and selecting, or making recommendations to our board of directors regarding nominees for election to our board of directors 
 and its committees;                                                                                                                      |
| ● | developing                                                                                                                               
 and overseeing the annual evaluation of our board of directors and of its committees;                                                    |
| ● | considering                                                                                                                              
 and making recommendations to our board of directors regarding the composition of our board of directors and its committees;             |
| ● | overseeing                                                                                                                               
 our corporate governance practices; and                                                                                                  |
| ● | making                                                                                                                                   
 recommendations to our board of directors regarding corporate governance guidelines.                                                     |

Our nominating and corporate governance committee will operate under a written charter that satisfies the applicable listing standards of Nasdaq, a copy of which will be available on our website.

Compensation Committee Interlocks and Insider Participation

None of the members of our compensation committee is a current or former executive officer or employee of our company. None of our executive officers serves as a member of the compensation committee of any entity that has one or more executive officers serving on our compensation committee.

Risk Oversight

One of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors administers this oversight function directly through our board of directors as a whole, and through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure, including risks associated with cybersecurity and